Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Toouli

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Obesity Surgery|October 17, 2015
Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 StudyScott A Shikora, James Toouli, Miguel F Herrera, et al.
Pancreas|December 5, 2009
Galanin mediates the pathogenesis of cerulein-induced acute pancreatitis in the mouseMayank Bhandari, Anthony C Thomas, Damian J Hussey, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 1, 2008
The tripeptide analog feG ameliorates severity of acute pancreatitis in a caerulein mouse modelYusnita Rifai, Alison S F Elder, Colin J Carati, et al.
Obesity Surgery|September 8, 2012
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesityMichael G Sarr, Charles J Billington, Roy Brancatisano, et al.
Obesity Surgery|February 16, 2019
Influence of Asian Ethnicities on Short- and Mid-term Outcomes Following Laparoscopic Sleeve GastrectomyZong Jie Koh, Bee Choo Tai, Lilian Kow, et al.
JAMA|September 4, 2014
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trialSayeed Ikramuddin, Robin P Blackstone, Anthony Brancatisano, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Obesity Surgery|October 17, 2015
Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 StudyScott A Shikora, James Toouli, Miguel F Herrera, et al.
Pancreas|December 5, 2009
Galanin mediates the pathogenesis of cerulein-induced acute pancreatitis in the mouseMayank Bhandari, Anthony C Thomas, Damian J Hussey, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 1, 2008
The tripeptide analog feG ameliorates severity of acute pancreatitis in a caerulein mouse modelYusnita Rifai, Alison S F Elder, Colin J Carati, et al.
Obesity Surgery|September 8, 2012
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesityMichael G Sarr, Charles J Billington, Roy Brancatisano, et al.
Obesity Surgery|February 16, 2019
Influence of Asian Ethnicities on Short- and Mid-term Outcomes Following Laparoscopic Sleeve GastrectomyZong Jie Koh, Bee Choo Tai, Lilian Kow, et al.
JAMA|September 4, 2014
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trialSayeed Ikramuddin, Robin P Blackstone, Anthony Brancatisano, et al.
Pageof 5